Open AccessCorticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19
Author(s) -
Keith Sultan,
Laura Durbin,
Richa Bhardwaj,
James Mackey,
Noah Becher,
Mohammad Abureesh,
Komal Lakhani,
Anjali Mone,
Jeffrey Abergel,
Arvind J. Trindade,
Burton I. Korelitz,
Arun Swaminath
Publication year - 2021
Publication title -
gastroenterology research
Language(s) - English
Resource type - Journals
eISSN - 1918-2813
pISSN - 1918-2805
DOI - 10.14740/gr1447
Subject(s) - medicine , inflammatory bowel disease , covid-19 , population , retrospective cohort study , disease , adverse effect , corticosteroid , intensive care medicine , pediatrics , infectious disease (medical specialty) , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom